The Carlyle Group led a USD123m Series D for China-based biotech firm Abbisko, with participation from Warburg Pincus, OrbiMed, and Lake Bleu Capital. Janchor Partners, Sage Partners, SHC, and Greater Bay Area Homeland Development Fund also participated in the round, and existing investors Lilly Asia Ventures, Temasek Holdings, Qiming Venture Partners, Hankang Capital, and CICC Capital followed on. Read more